Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivors

Abstract Quitting smoking could potentially minimize the risk of a high neutrophil-to-lymphocyte ratio (NLR) among tobacco use-related (TUR) cancer survivors. A total of 1263 TUR cancer survivors aged 20 to 85 years old were investigated using data from the National Health and Nutritional Examinatio...

Full description

Bibliographic Details
Main Authors: You Lu, Katherine Kwong, James Wells, Andrea Edwards, Zhong Chen, Tung-Sung Tseng, Kun Zhang
Format: Article
Language:English
Published: Nature Portfolio 2023-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-27624-1
_version_ 1797864698510573568
author You Lu
Katherine Kwong
James Wells
Andrea Edwards
Zhong Chen
Tung-Sung Tseng
Kun Zhang
author_facet You Lu
Katherine Kwong
James Wells
Andrea Edwards
Zhong Chen
Tung-Sung Tseng
Kun Zhang
author_sort You Lu
collection DOAJ
description Abstract Quitting smoking could potentially minimize the risk of a high neutrophil-to-lymphocyte ratio (NLR) among tobacco use-related (TUR) cancer survivors. A total of 1263 TUR cancer survivors aged 20 to 85 years old were investigated using data from the National Health and Nutritional Examination Survey 1999–2018. The primary outcome was the NLR, which was defined as having two levels: high-risk (≥ 3) and low-risk (< 3). The association between smoking cessation time and a high-risk NLR level was analyzed using weighted logistic regression models. Overall, the current smoking rate of TUR cancer survivors was found to be 21.7%. Older age (75 years above), gender and respiratory-related cancers are covariables associated with high risk of NLR levels for individual who identified as Non-Hispanic White (NHW). Non-Hispanic Black (NHB) (n = 27) who quit smoking after a cancer diagnosis were associated with the highest risk of a high NLR (OR 4.83, 95% CI 1.40–16.61, p = 0.01) compared to NHB nonsmokers (n = 139). These findings suggest that the risk of a high NLR level is strongly associated with the time of smoking cessation in NHB TUR cancer survivors. As a result, NHB TUR cancer survivors should quit smoking as soon as possible because the benefits of quitting smoking were observed over the 5 year period following smoking cessation.
first_indexed 2024-04-09T22:56:12Z
format Article
id doaj.art-77957bdc612143be87cb77f252456afa
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-09T22:56:12Z
publishDate 2023-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-77957bdc612143be87cb77f252456afa2023-03-22T11:14:07ZengNature PortfolioScientific Reports2045-23222023-02-0113111110.1038/s41598-023-27624-1Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivorsYou Lu0Katherine Kwong1James Wells2Andrea Edwards3Zhong Chen4Tung-Sung Tseng5Kun Zhang6Department of Physics and Computer Science, Xavier University of LouisianaDepartment of Human Development, Connecticut CollegeDepartment of Physiology, Tulane UniversityDepartment of Physics and Computer Science, Xavier University of LouisianaDepartment of Physics and Computer Science, Xavier University of LouisianaBehavioral and Community Health Science, School of Public Health, Louisiana State University Health Science CenterDepartment of Physics and Computer Science, Xavier University of LouisianaAbstract Quitting smoking could potentially minimize the risk of a high neutrophil-to-lymphocyte ratio (NLR) among tobacco use-related (TUR) cancer survivors. A total of 1263 TUR cancer survivors aged 20 to 85 years old were investigated using data from the National Health and Nutritional Examination Survey 1999–2018. The primary outcome was the NLR, which was defined as having two levels: high-risk (≥ 3) and low-risk (< 3). The association between smoking cessation time and a high-risk NLR level was analyzed using weighted logistic regression models. Overall, the current smoking rate of TUR cancer survivors was found to be 21.7%. Older age (75 years above), gender and respiratory-related cancers are covariables associated with high risk of NLR levels for individual who identified as Non-Hispanic White (NHW). Non-Hispanic Black (NHB) (n = 27) who quit smoking after a cancer diagnosis were associated with the highest risk of a high NLR (OR 4.83, 95% CI 1.40–16.61, p = 0.01) compared to NHB nonsmokers (n = 139). These findings suggest that the risk of a high NLR level is strongly associated with the time of smoking cessation in NHB TUR cancer survivors. As a result, NHB TUR cancer survivors should quit smoking as soon as possible because the benefits of quitting smoking were observed over the 5 year period following smoking cessation.https://doi.org/10.1038/s41598-023-27624-1
spellingShingle You Lu
Katherine Kwong
James Wells
Andrea Edwards
Zhong Chen
Tung-Sung Tseng
Kun Zhang
Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivors
Scientific Reports
title Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivors
title_full Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivors
title_fullStr Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivors
title_full_unstemmed Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivors
title_short Quitting smoking after a cancer diagnosis is associated with high-risk neutrophil-to-lymphocyte ratio among tobacco use-related cancer survivors
title_sort quitting smoking after a cancer diagnosis is associated with high risk neutrophil to lymphocyte ratio among tobacco use related cancer survivors
url https://doi.org/10.1038/s41598-023-27624-1
work_keys_str_mv AT youlu quittingsmokingafteracancerdiagnosisisassociatedwithhighriskneutrophiltolymphocyteratioamongtobaccouserelatedcancersurvivors
AT katherinekwong quittingsmokingafteracancerdiagnosisisassociatedwithhighriskneutrophiltolymphocyteratioamongtobaccouserelatedcancersurvivors
AT jameswells quittingsmokingafteracancerdiagnosisisassociatedwithhighriskneutrophiltolymphocyteratioamongtobaccouserelatedcancersurvivors
AT andreaedwards quittingsmokingafteracancerdiagnosisisassociatedwithhighriskneutrophiltolymphocyteratioamongtobaccouserelatedcancersurvivors
AT zhongchen quittingsmokingafteracancerdiagnosisisassociatedwithhighriskneutrophiltolymphocyteratioamongtobaccouserelatedcancersurvivors
AT tungsungtseng quittingsmokingafteracancerdiagnosisisassociatedwithhighriskneutrophiltolymphocyteratioamongtobaccouserelatedcancersurvivors
AT kunzhang quittingsmokingafteracancerdiagnosisisassociatedwithhighriskneutrophiltolymphocyteratioamongtobaccouserelatedcancersurvivors